BIO-key International, Inc. (BKYI) — Analyst outlook / Analyst consensus target is. Based on 1 analyst ratings, the consensus is bullish — 1 Buy.
Analysts estimate Earnings Per Share (EPS) of $-1.86 and revenue of $0.01B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $-0.03 vs est $-1.86 (beat +98.2%). 2025: actual $-0.69 vs est $-0.50 (missed -38%). Analyst accuracy: 0%.
BKYI Analyst Ratings
Buy
Based on 1 analysts giving stock ratings to BIO-key International, Inc. in the past 3 months
EPS Estimates — BKYI
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$0.03
vs Est –$1.86
▲ 5,536.4% off
2025
Actual –$0.69
vs Est –$0.50
▼ 27.5% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
Revenue Estimates — BKYI
84%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $0.007B
vs Est $0.008B
▼ 12.6% off
2025
Actual $0.006B
vs Est $0.007B
▼ 19.8% off
Revenue Trend
Revenue has declined over the period shown. Analysts forecast significant revenue growth ahead.
